Publication:
Recurrence Patterns after Surgery in Patients with Different Endometriosis Subtypes: A Long-Term Hospital-Based Cohort Study.

cris.virtual.author-orcid0000-0002-2631-8063
cris.virtual.author-orcid0000-0002-9881-1252
cris.virtualsource.author-orcid11850d00-ef2f-4ca8-a7d4-935ade0e6d9c
cris.virtualsource.author-orcidbbc72196-cda3-44d4-9974-58fe6974d693
cris.virtualsource.author-orcid8f0fb243-dbd0-4db2-91d6-32503b556a93
cris.virtualsource.author-orcid739973bf-27d2-4e55-932c-d9b5649868a0
datacite.rightsopen.access
dc.contributor.authorNirgianakis, Konstantinos
dc.contributor.authorMa, Lijuan
dc.contributor.authorMc Kinnon, Brett
dc.contributor.authorMueller, Michael
dc.date.accessioned2024-09-21T05:53:59Z
dc.date.available2024-09-21T05:53:59Z
dc.date.issued2020-02-11
dc.description.abstractRecurrence of endometriosis after surgery constitutes a serious challenge. Whether there is an evolution of lesion subtypes with each recurrence and whether certain lesions subtypes tend to recur faster than others is not adequately addressed. Medical records of all patients who underwent surgery for endometriosis between 1997 and 2018 in the Department of Gynecology and Obstetrics, University of Bern, were reviewed. Inclusion criteria was surgically confirmed endometriosis recurrence, defined as a subsequent surgery for endometriosis after a previous complete surgical excision of endometriosis lesions. Three subtypes of endometriosis were defined: superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA), and deep infiltrating endometriosis (DIE). Time to recurrence and variation in endometriosis subtype between the first and recurrent surgeries were the primary outcome measures. Out of the 322 patients with recurrent surgery that were identified, for 234 of them, the endometriosis subtype at first surgery was confirmed and classified (SUP = 56, OMA = 124, DIE = 54). No statistically significant difference was found for time to recurrence between lesion subtypes. SUP compared to the other groups had a higher possibility of presenting with SUP at recurrence (Odds Ratio (OR): 3.65, 95% confidence interval (CI): 1.74-7.51) and OMA compared to the other groups had a higher possibility of presenting with OMA at recurrence (OR: 3.72, 95% CI: 2.04-6.74). Nevertheless, a large number of SUP patients subsequently presented with OMA (10/56: 17.9%) or DIE (27/56: 48.2%) lesions at recurrence. Similarly, a large number of OMA patients subsequently presented with DIE (49/124: 39.5%) lesions at recurrence. In conclusion, although SUP and OMA patients compared to the others are more likely to present with the same subtype at recurrence, increasing lesion subtype severity occurs in a substantial proportion of patients. Time to recurrence is independent from the lesion subtype at first surgery.
dc.description.numberOfPages11
dc.description.sponsorshipDepartment for BioMedical Research, Forschungsgruppe Endometriose und gynäkologische Onkologie
dc.description.sponsorshipUniversitätsklinik für Frauenheilkunde
dc.identifier.doi10.48350/150091
dc.identifier.pmid32054117
dc.identifier.publisherDOI10.3390/jcm9020496
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/45284
dc.language.isoen
dc.publisherMDPI
dc.relation.ispartofJournal of clinical medicine
dc.relation.issn2077-0383
dc.relation.organizationClinic of Gynaecology
dc.relation.organizationDepartment for BioMedical Research, Forschungsgruppe Endometriose und gynäkologische Onkologie
dc.subjectdeep-infiltrative endometriosis endometrioma peritoneal endometriosis progression recurrence
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleRecurrence Patterns after Surgery in Patients with Different Endometriosis Subtypes: A Long-Term Hospital-Based Cohort Study.
dc.typearticle
dspace.entity.typePublication
oaire.citation.issue2
oaire.citation.volume9
oairecerif.author.affiliationDepartment for BioMedical Research, Forschungsgruppe Endometriose und gynäkologische Onkologie
oairecerif.author.affiliationUniversitätsklinik für Frauenheilkunde
oairecerif.author.affiliationDepartment for BioMedical Research, Forschungsgruppe Endometriose und gynäkologische Onkologie
oairecerif.author.affiliationUniversitätsklinik für Frauenheilkunde
oairecerif.author.affiliation2Universitätsklinik für Frauenheilkunde
oairecerif.author.affiliation2Department for BioMedical Research, Forschungsgruppe Endometriose und gynäkologische Onkologie
oairecerif.author.affiliation2Universitätsklinik für Frauenheilkunde
oairecerif.author.affiliation2Department for BioMedical Research, Forschungsgruppe Endometriose und gynäkologische Onkologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2021-01-05 10:11:54
unibe.description.ispublishedpub
unibe.eprints.legacyId150091
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
32054117.pdf
Size:
616.71 KB
Format:
Adobe Portable Document Format
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections